Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 3/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.51 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.43 |
| ▸ | SPHK1 | Q9NYA1 | 5/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10341942 | 1.00 | CYP2C9 (0.61) | CYP2C9MAPTALDH1A1LMNAMEN1 | |
| SCHEMBL7661308 | 0.96 | CYP2C9 (0.57) | CYP2C9MAPTALDH1A1LMNAMEN1 | |
| SCHEMBL10766628 | 0.96 | CYP2C9 (0.57) | CYP2C9MAPTALDH1A1LMNAMEN1 | |
| SCHEMBL10766638 | 0.96 | CYP2C9 (0.57) | CYP2C9MAPTALDH1A1LMNAMEN1 | |
| SCHEMBL10766643 | 0.96 | CYP2C9 (0.57) | CYP2C9MAPTALDH1A1LMNAMEN1 | |
| SCHEMBL7661304 | 0.96 | CYP2C9 (0.57) | CYP2C9MAPTALDH1A1LMNAMEN1 | |
| SCHEMBL9501207 | 0.95 | CYP2C9 (0.62) | CYP2C9MAPTALDH1A1LMNAMEN1 | |
| SCHEMBL19870479 | 0.95 | CYP2C9 (0.62) | CYP2C9MAPTALDH1A1LMNAMEN1 | |
| SCHEMBL10763490 | 0.95 | CYP2C9 (0.56) | CYP2C9MAPTALDH1A1LMNAMEN1 | |
| SCHEMBL10763487 | 0.95 | CYP2C9 (0.56) | CYP2C9MAPTALDH1A1LMNAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4686757-A1 | INHIBITORS OF EXPRESSION AND/OR FUNCTION | e-therapeutics PLC (GB) | 2026-02-04 | — | — | EP | disclosed |
| CN-116535303-B | Method for synthesizing 4- (4-alkyl cyclohexyl) aryl ketone by replacing dichloroethane with methylcyclohexane | 山东齐阳光电科技有限公司 | 2023-09-05 | — | — | CN | disclosed |
| CN-116535303-A | Method for synthesizing 4- (4-alkyl cyclohexyl) aryl ketone by replacing dichloroethane with methylcyclohexane | 山东齐阳光电科技有限公司 | 2023-08-04 | — | — | CN | disclosed |
| US-20150337013-A1 | NOVEL ANTIBACTERIAL AGENTS FOR THE TREATMENT OF GRAM POSITIVE INFECTIONS | MERCK SHARP & DOHME CORP. (US) | 2015-11-26 | — | — | US | disclosed |
| US-20140073558-A1 | NOVEL ANTIBACTERIAL AGENTS FOR THE TREATMENT OF GRAM POSITIVE INFECTIONS | CUBIST PHARMACEUTICALS, INC. (US) | 2014-03-13 | — | — | US | disclosed |
| US-8507647-B2 | Antibacterial agents for the treatment of gram positive infections | CUBIST PHARMACEUTICALS, INC. (US) | 2013-08-13 | — | — | US | disclosed |
| EP-1762605-B1 | Naphthalene compound with terminal hydrogen, liquid crystal composition including the compound, and LCD device including the liquid crystal composition | CHISSO PETROCHEMICAL CORP (JP) | 2010-10-13 | — | — | EP | disclosed |
| US-5188759-A | HALOACETYLENE DERIVATIVES | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1993-02-23 | — | — | US | disclosed |
| EP-0149238-B1 | NITROGEN CONTAINING HETEROCYCLES | MERCK PATENT GmbH (DE) | 1990-02-28 | — | — | EP | disclosed |
| US-4726911-A | Heterocyclic compounds | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1988-02-23 | — | — | US | disclosed |
| US-4713197-A | Nitrogen-containing heterocyclic compounds | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1987-12-15 | — | — | US | disclosed |
| US-4694098-A | WIDE MESOMORPHIC RANGE | HITACHI, LTD. (JP) | 1987-09-15 | — | — | US | disclosed |
| EP-0182054-A2 | Heterocyclic compounds | MERCK PATENT GmbH (DE) | 1986-05-28 | — | — | EP | disclosed |
| EP-0058981-B1 | COLORLESS LIQUID CRYSTALLINE COMPOUNDS | Hitachi, Ltd. (JP) | 1986-01-22 | — | — | EP | disclosed |
| US-4564694-A | CYCLOHEXYL AND PHENYL RING-CONTAINING ALIPHATIC ETHERS | HITACHI, LTD. (JP) | 1986-01-14 | — | — | US | disclosed |
| EP-0149238-A2 | Nitrogen containing heterocycles | MERCK PATENT GmbH (DE) | 1985-07-24 | — | — | EP | disclosed |
| EP-0058981-A2 | Colorless liquid crystalline compounds | Hitachi, Ltd. (JP) | 1982-09-01 | — | — | EP | disclosed |
| US-4130502-A | Liquid crystalline cyclohexane derivatives | MERCK PATENT GESELLSCHAFT MIT (DE) | 1978-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150337013-A1 | NOVEL ANTIBACTERIAL AGENTS FOR THE TREATMENT OF GRAM POSITIVE INFECTIONS | CLPP, CLPTM1, RPN1 | CYP2C9 4640/4885MAPT 4574/4885ALDH1A1 4703/4885 |
| US-20140073558-A1 | NOVEL ANTIBACTERIAL AGENTS FOR THE TREATMENT OF GRAM POSITIVE INFECTIONS | CLPP, CLPTM1, RPN1 | CYP2C9 4640/4885MAPT 4574/4885ALDH1A1 4703/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.